EARKART LIMITED

Healthcare · Healthcare Equipment & Supplies

BSE: 544549
₹130.00
▲ 0.00 (0.00%)
Sept. 28, 2026 · BSE · bse_bhavcopy
Quality
50/100
Moderate
Valuation
—/100
Data unavailable
Momentum
49/100
Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
₹-18 Cr
as of March 31, 2026
Industry median ₹-4 Cr (17 companies)
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
12.67
as of March 31, 2026
Industry median 3.04 (17 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.11 (12 companies)
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 3 met
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • Yes Net cash flow for the latest year is positive

Ownership

1 of 1 met
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Value and momentum

1 of 2 met
  • No Momentum score is Bullish (70 or more)
  • Yes Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
0.0%
Low 126.0000 · High 130.0000
1W return
0.0%
Low 126.0000 · High 130.0000
1M return
6.6%
Low 112.0000 · High 151.9500
52W return
Data unavailable.
Low 112.0000 · High 151.9500
Lifetime High ₹151.9500 (Sept. 18, 2026)
Lifetime Low ₹112.0000 (Sept. 7, 2026)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish2
5D
132.6
10D
130.7

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
71.4%
Month avg. delivery
81.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

128.67
Pivot
First resistance131.33
Second resistance132.67
Third resistance135.33
First support127.33
Second support124.67
Third support123.33
Day RSI49.2
Day MFI74.9
Day MACD—
Day MACD signal—

Beta

1M—
3M—
1Y—
3Y—

Price change analysis

↑ 6.6%
Over 1 Month
LowHigh
112.00151.95
—
Over 3 Months
LowHigh
112.00151.95
—
Over 6 Months
LowHigh
112.00151.95
—
Over 1 Year
LowHigh
112.00151.95
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (Sept. 30, 2025)
₹— Cr
Net profit (Sept. 30, 2025)
₹— Cr
Basic EPS (Sept. 30, 2025)
₹0.0000

Ranks #None of 13 in Healthcare Equipment & Supplies by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Mar 2026
  • Promoter57.34%

Largest holders

Data unavailable.

Historical promoter holding

All shareholding details →

DateClientDealActionQuantityPriceExchange
20 Apr 2026 NEOMILE GROWTH FUND-SERIES I Bulk Buy 1,000 139.0000 BSE
20 Apr 2026 NEOMILE GROWTH FUND-SERIES I Bulk Sell 70,000 140.0000 BSE
20 Apr 2026 AVORA SME FUND 1 Bulk Buy 72,000 139.7500 BSE
4 Mar 2026 NEOMILE GROWTH FUND-SERIES I Bulk Buy 857,000 125.0000 BSE
4 Mar 2026 NEOMILE CORPORATE ADVISORY PRIVATE LIMITED Bulk Sell 861,000 125.0000 BSE
14 Oct 2025 RIKHAV SECURITIES LIMITED Bulk Buy 5,000 186.5700 BSE
14 Oct 2025 RIKHAV SECURITIES LIMITED Bulk Sell 185,000 181.2600 BSE
14 Oct 2025 NEOMILE CORPORATE ADVISORY PRIVATE LIMITED Bulk Buy 213,000 183.9300 BSE
3 Oct 2025 AFCO INVESTMENTS SERVICES PRIVATE LIMITED Bulk Buy 75,000 135.5000 BSE
3 Oct 2025 KIRTI BEARINGS PRIVATE LIMITED Bulk Buy 212,000 142.2500 BSE

All bulk and block deals →

Corporate Announcements

All 1 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
28 Sep 2026 Insider Trading / SAST Earkart Ltd - 544549 - Closure of Trading Window

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.00)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about EARKART LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.